Navigation Links
Fleet Phospho-Soda Recalled
Date:12/15/2008

NEW YORK, Dec. 15 /PRNewswire/ -- An over the counter drug used to cleanse the bowel before colonoscopy was recalled last week because of serious side effects including destruction of the kidneys. The product, Fleet Phospho-Soda, made by C.B. Fleet, Co., of Virginia, is involved in product liability lawsuits around the country. The law firm of Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, has filed suit on behalf of a number of patients with kidney damage who used Fleet's product.

Fleet's recall followed the release of a Safety Alert by the Food and Drug Administration on Thursday warning consumers not to use over-the-counter laxatives, including Fleet's, in preparation for a colonoscopy due to the risk of kidney damage. The FDA will also now require prescription bowel cleansers, such as Visicol, to carry a black box warning about the risk of kidney damage. Since Fleet's is not a prescription product, it could not comply with the new FDA requirements, thus leading to the recall.

The lawsuits against Fleet allege that it improperly marketed Phospho-Soda at higher dosages than permitted by the FDA for over-the-counter oral laxatives containing sodium phosphate. "The FDA regulations are clear about the maximum daily dosage for these products, but Fleet continued for many years up until this recall to advise doctors and consumers to use twice the daily amount of its product that was permitted by the FDA," said Thomas P. Valet of the Rheingold, Valet law firm.

The safety of the higher dosages has never been demonstrated, according to Valet, who said that the higher dosage leads to deposits of calcium and phosphate in the kidneys, a condition known as nephrocalcinosis. In most cases, damage to the kidneys is permanent, requiring dialysis or even a transplant. The risk of kidney damage is increased in certain patients, according to Valet, including patients taking certain blood pressure medications or diuretics, and the risk of kidney damage increases with a patient's age. Valet said, however, that even those without a pre-existing risk factor can develop kidney failure after using Fleet's.

The link between kidney damage and Fleet's was first reported by a group of doctors in New York in 2003. Valet said that doctors from this group are working with his firm on behalf of injured patients and have been invaluable in helping prepare the cases against Fleet.

Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, is a New York based firm which handles mass tort litigation involving drugs and devices nationwide for the plaintiff's side. Partners in the firm have participated in the management of dozens of drug and medical device class actions and consolidated lawsuits around the country.

Contact: Thomas P. Valet, Esq. Or Paul D. Rheingold, Esq. (212)684-1880


'/>"/>
SOURCE Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fleeting Facial Expressions Reveal Deep Secrets
2. Sikorsky Aircraft and PHI Celebrate Fleet Expansion and 20K Milestone at Heli-Expo
3. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
4. TriWest On Deck to Support Fleet Week San Diego
5. Jay C Stores Ask Customers to Check for Recalled Ground Beef
6. Study finds that recalled Aqua Dots did contain poisonous chemical
7. FDA Finds Contaminant in Baxters Recalled Heparin Products
8. Deli Chef Tri-Bean Salad Recalled From Some Kroger Stores
9. Common Infant Vaccine Recalled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: